The global tissue sectioning market size is expected to reach USD 862.24 million by 2027, registering a CAGR of 6.56% during the forecast period, according to a new report published by Grand View Research, Inc. A rise in prevalence of cancer coupled with the awareness among physicians regarding the use of tissue diagnostic procedures for prognostication and diagnostics is expected to fuel the growth.
As per the NIH-National Cancer Institute, the number of new cancer cases is expected to rise to 23.6 million by 2030. Germany ranks in the top 5 countries that have super-aged societies. It is expected that one-third of the total population of Germany will be above 65 year of age by 2050. This increases the change of encountering cancer, liver and kidney disorders, autoimmune diseases, and infections.
As the analysis of tissue sections is helpful in the management and identification of clinical disorders, thus a rise in the geriatric population leads to a rise in demand for tissue sectioning equipment for effective and rapid tissue diagnostics. In addition, shifting focus of the researchers and pathologists toward exploring the cancer staging in rare types of cancer is anticipated to boost the market growth in the forthcoming years.
A rise in the number of histology laboratories globally is a key driving factor for the market. In addition, constant rise in the number of certified pathologists in Canada and other major countries is expected to support the projected growth of the market. These laboratories are adopting novel protocols that aid in troubleshooting the challenges associated with tissue processing.
Get Details For “Sample Report, TOC, Segmentation & methodology of Tissue Sectioning Market” Click Link Below:
https://www.grandviewresearch.com/industry-analysis/tissue-sectioning-market
Further key findings from the report suggest:
Instruments accounted for the largest market share in 2019 owing to the presence of a substantial commercially available product base, ongoing technological advancements, and lack of any external substitute for tissue sectioning equipment
Rotary microtome is the most-commonly used microtomes in a histopathology lab, thereby leading to its prominent revenue share
Automatic technology is expected to occupy substantial share of the technology segment in 2019 as these products enable cutting of thin tissue sectioning with a high precision consistently
Automated devices also enhance productivity by enhancing the speed and efficiency of the process. These devices are user-friendly as they reduce the need for repetitive motion of the microtome
Disease diagnosis dominated the applications segment in 2019 owing to a rise in adoption of histopathology techniques for the diagnosis of cancer and other disorders
An accurate pathology analysis is crucial for the diagnosis and determination of a treatment plan for patients. This increases the utilization of microtomes and cryostats in histopathology laboratories for disease diagnosis
Hospitals end-user segment is projected to continue holding the largest market share during the forecast period, as hospitals are the key facilities for the analysis of tissue specimen
Presence of a large number of hospitals with in-house pathology laboratories for analysis of biopsy specimen is expected to boost the segment growth
North America held the largest share of the tissue sectioning market in 2019. Asia Pacific, on the other hand, is expected to register the fastest CAGR in the forthcoming years
Some key market players include Thermo Fisher Scientific, Leica Biosystems Nussloch GmbH, LLS ROWIAK LaserLabSolutions GmbH, and Sakura Finetek Europe B.V.
Would you Like to Take a Look On “Sample Report” of Tissue Sectioning Market Click the Link Below:
https://www.grandviewresearch.com/industry-analysis/tissue-sectioning-market/request/rs1
Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/7110/ibb
Grand View Research has segmented the global tissue sectioning market report on the basis of product, technology, application, end-use, and region:
Tissue Sectioning Product Outlook (Revenue, USD Million, 2016 – 2027)
Instruments
Rotary Microtome
Sliding Microtome
Ultramicrotome
Cryostat
Others
Accessories & Consumables
Services
Tissue Sectioning Technology Outlook (Revenue, USD Million, 2016 – 2027)
Automatic
Semiautomatic
Manual
Tissue Sectioning Application Outlook (Revenue, USD Million, 2016 – 2027)
Diagnosis
Research
Tissue Sectioning End-use Outlook (Revenue, USD Million, 2016 – 2027)
Hospitals
Clinics
Diagnostic Laboratories
Research Centers
Tissue Sectioning Regional Outlook (Revenue, USD Million, 2016 – 2027)
North America
U.S.
Canada
Europe
Germany
U.K.
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Middle East and Africa (MEA)
South Africa
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 126 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 4126 analysts and consultants, the company adds 121200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 600 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: https://www.grandviewresearch.com/industry-analysis/tissue-sectioning-market